Yukari Nishito

An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors

Takahiro Ishiguro, Yuji Sano, Shunichiro Komatsu et al. · Science Translational Medicine · 2017 · 195 citations

Whole genome assembly of a natto production strain Bacillus subtilis natto from very short read data

Yukari Nishito, Yasunori Osana, Tsuyoshi Hachiya et al. · BMC Genomics · 2010 · 108 citations · Full text

The molecular rationale for the combination of polatuzumab vedotin plus rituximab in diffuse large B‐cell lymphoma

Natsumi Kawasaki, Yukari Nishito, Yasushi Yoshimura et al. · British Journal of Haematology · 2022 · 23 citations · Full text

Lymphoid Neoplasia, Pola-refractory Cells, Medicine +12

Neutrophil-to-lymphocyte ratio is a prognostic factor reflecting immune condition of tumor microenvironment in squamous cell lung cancer

Kana Ohashi, Yukari Nishito, Hironori Fukuda et al. · Scientific Reports · 2024 · 22 citations · Full text

Combination of T cell-redirecting bispecific antibody ERY974 and chemotherapy reciprocally enhances efficacy against non-inflamed tumours

Yuji Sano, Yumiko Azuma, Toshiaki Tsunenari et al. · Nature Communications · 2022 · 18 citations · Full text